QI Intervention Aids Medication Safety for Elderly in ER

This article originally appeared here.
Share this content:
QI Intervention Aids Medication Safety for Elderly in ER
QI Intervention Aids Medication Safety for Elderly in ER

THURSDAY, April 20, 2017 (HealthDay News) -- A quality improvement initiative that combines education, electronic clinical decision support, and individual provider feedback can positively influence prescribing behavior and improve medication safety for older adults in the emergency department, according to a study published online April 7 in the Journal of the American Geriatrics Society.

Melissa Stevens, M.D., from Emory University in Atlanta, and colleagues evaluated the effectiveness and sustainability of the EQUiPPED quality improvement initiative to reduce the use of potentially inappropriate medications (PIMs), as defined by the American Geriatrics Society 2012 Beers Criteria, prescribed to older veterans at the time of emergency department discharge. Patients discharged six months prior to the first EQUiPPED intervention and for at least 12 months following the final EQUiPPED intervention were compared.

The researchers found that all four sites showed a significant and sustained reduction in use of PIMs from the pre-EQUiPPED period to the post-EQUiPPED period (site one: from 11.9 to 5.1 percent [P < 0.0001]; site two: 8.2 to 4.5 percent [P < 0.0001]; site three: 8.9 to 6.1 percent [P = 0.0007]; site four: 7.4 to 5.7 percent [P = 0.04]).

"These results suggest a multicomponent program to influence provider prescribing behavior leads to safer prescribing for older adults discharged from the emergency department and is sustainable across multiple Veterans Affairs emergency department sites," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for &#126;25&#37; ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »